Gurpreet Sodhi
Deniz Senturk
Deniz is the Head of Analytics and Chief Risk Officer, supporting Global Treasury, at State Street Corporation (SSC). In her role as Head of Analytics, Deniz is focused on providing quantitative solutions consisting of Predictive Analytics and Business Intelligence (data analytics, reporting) for business lines across the bank. In parallel, she is also responsible for risk oversight of Treasury’s activities, which includes managing the investment portfolio, asset-liability risk, liquidity risk, funding and liability pricing, and capital structure, in her role as CRO for Treasury.
Prior to her current role, Deniz was the Head of Model Risk Management at State Street for three years and headed up Model Risk Management within GE Capital for 3+ years before joining State Street in 2015. Deniz’s 15 year tenure at GE also included leading the marketing analytics teams as well as the research teams within GE Global Research Center. During her time at GE, she published 15+ patents and 20+ research papers on advanced statistical techniques used in risk and finance.
Deniz’s areas of functional expertise include compliance and control functions, credit, treasury, market and model risk management in addition to risk analytics, marketing analytics and business strategy management. She also served as an adjunct professor at the Graduate School of Business, Fordham University for three years.
Deniz holds a Ph.D. in Applied Statistics from University of California, Santa Barbara and a B.S. in Physics from Bogazici University (Turkey).
Chandra Khandrika
Chandra Sekhar Khandrika is Head of IA Model risk management at Citi Bank. He has 20 years of industry experience in Risk and Control areas including Risk Management, Independent valuation, and audit at global Investment banks. His interests are in the intersection of financial risk and climate risks. He is interests in the nexus of climate risk regulatory landscape and low carbon economy transition. Specifically, embedding climate risk management framework, stress testing, scenario analysis and disclosures. Low carbon economy transition and adaptation and mitigation strategies leveraging clean technologies.
Ahmed Elcott
Ahmed Elcott is an executive vice president and the head of Climate Risk at Wells Fargo where he leads the firm’s climate risk initiative. In this role, he leads the integration of climate risk into the firm’s overall risk management framework.
Cem Torunoglu
Mohammed Iqbal
Mohammed Iqbal strives to enhance people’s lives. He believes the key to leading a healthier life is having access to fitness knowledge and acting on it. He founded SweatWorks, the leading digital agency in fitness design and technology to create meaningful wellness journeys for everyone.
As founder and CEO, Mohammed has established SweatWorks as a wellness technology brand unlike any other. The agency pursues innovation to make fitness engaging, beautiful and accessible to all.
Mohammed also contributes to the wellness industry via speaking engagements at leading events and fitness conferences around the world. His personal commitment to his fitness journey is an inspiration to all those he comes in contact with. Daily, he immerses himself in strategic and creative thinking, fitness, and innovation. For ten years Mohammed has worked at exploring the intersection of fitness and technology, paving the way towards a more tangible wellness and healthcare future
SweatWorks collaborates with top-tier fitness brands to provide design, technology and marketplace expertise to produce first-to-market fitness and wellness products. It has made the Inc 5000 list as one of the fastest growing private companies five years in a row.
Allison Watkins
John Lu
John Lu
Shi-Jiang (John) Lu, PhD, MPH, is currently the President and CEO of HebeCell Corporation, focusing on the development and clinical translation of regenerative medicine and cell therapy technologies, especially iPS-CAR-NK cells for the treatment of cancer, autoimmune and viral infectious diseases. Before establishing HebeCell, he was the Senior Director of Research at Advanced Cell Technology/Ocata Therapeutics, which was acquired by Astellas Pharma in 2016. John is an expert in stem cell biology and regenerative medicine with 20 years of experiences. He has been conducting translational researches and discovery of novel therapeutic strategies utilizing human embryonic stem cells (hESC), induced pluripotent stem cells (iPSC) and their derivatives. The goal of his research is to generate hESC/iPSC-derived products for the treatment of human diseases. He also has extensive experience in process development and large-scale production of human PSC derivatives under defined conditions for clinical trials. John is the inventor of more than 20 patents in stem cell field: in an analysis of global stem cell patent landscape by Nature Biotechnology in 2014, John’s patent application and citation ranked No. 7 and No. 5, respectively. In addition to stem cell research, Dr. Lu also has more than 10 year experiences in cancer research. John received his BS degree in Biochemistry from Wuhan University, MSc degree in Oncology/Pathophysiology from Peking Union Medical College, MPH degree in Molecular Toxicology/Environmental Sciences from Columbia University and PhD degree in Molecular Cancer Biology from University of Toronto.